Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

Published Date: 04 Jun 2025

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted therapy, reduces the frequency of vasomotor symptoms, ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.

3.

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

4.

Study shows virtual reality headsets may help ease cancer pain

5.

Nasal therapeutic HPV vaccine could prevent cervical cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot